Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2b randomized trial of AZD9668 in COPD patients treated with tiotropium
jRCT2080221030Phase 2
- Sponsor
- AstraZeneca
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of alvelestat in chronic obstructive pulmonary disease (COPD) (4 arms), sponsored by AstraZeneca.
02
Drugs
alvelestat
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on jRCT2080221030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221030.